Consider this 02/27/2025 article by Steve Bryson, PhD titled: “Hepatitis C telemedicine approach for opioid users receives award” is eye-opening–
“A program using a telemedicine approach to treat hepatitis C in people with opioid use disorder that resulted in the cure of more than 90% of its participants won a 2025 Top Ten Clinical Research Achievement Award from the Clinical Research Forum.
The award recognizes groundbreaking achievements in clinical research nationwide, focusing on innovative studies that improve the understanding of diseases and their prevention and treatment. A panel selected winners based on published research from 2024.
‘Unfortunately, many people with hepatitis C are not treated for a variety of reasons,’ Andrew H. Talal, a professor of medicine at the Jacobs School of Medicine and Biomedical Sciences at the University of Buffalo and attending physician at Buffalo General Medical Center, said in a university news story. ‘Facilitated telemedicine integrated into opioid treatment programs is an extremely effective approach to bring treatment to those who need it.’”
–> LiverRight treats HBV and HCV virtually in all fifty US states.